re: Ann: Prima Raises $20 million in Share Pu... from the Company announcement just sent via email
ASX/Media Release (Code: PRR)
28 June 2011
Prima BioMed raises $20 million in Share Purchase Plan
the closing paragraphs are critical ....
" Prima?s lead product is CVacTM ovarian cancer therapy treatment. It has completed two successful clinical trials and is progressing toward eventual commercialization in the United States, Australia, Europe, and globally. "
... and the juicy bit .....
" The Company?s broader, long term goal is to develop commercial cancer treatment technologies and programs for global markets. "
... seems like there may not only be a few more rabbits in the hat .... but a few bloody big elephants to come out of that same hat
... but ' technologies ' and treatments to compliment and / or supplement cVac .... oh the potential
.... now if that isn't exciting for the ' long term hold'... and years and years of income stream ... I don't know what is .
... sub 30c will be long gone in a fews weeks ... onwards and upwards
re: Ann: Prima Raises $20 million in Share Pu... from the...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $400.0M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.0¢ | $1.034M | 3.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 98156 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 85523 | 9 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |